Understanding MCI and Early Alzheimer's Disease: An Expert-Led Educational Series for GPs
Series Summary
This expert-led educational series provides GPs with practical guidance on recognising and managing patients with MCI and early Alzheimer's disease. Through insights from leading Australian experts Alzheimer’s disease, the series explores risk reduction, early detection, diagnosis, referral pathways, multidisciplinary management, follow-up care, and evidence-based interventions that can be implemented in everyday clinical practice. The series is designed to help GPs navigate the evolving Alzheimer's disease landscape and improve patient outcomes through earlier action and coordinated care.
Episode 1: What is MCI and how is it different to dementia?
Dr Mark Hohenberg
In this episode, Dr Mark Hohenberg explains the differences between normal ageing, MCI, and dementia, and discusses how early recognition of cognitive change can support timely assessment and intervention.
Episode 2: Reducing the Risk of Alzheimer’s Disease
Dr Marita Long
Dr Marita Long discusses modifiable risk factors for Alzheimer's disease and the practical steps GPs can take to support lifelong brain health and risk reduction in their patients.
Episode 3: Healthy ageing through proactive measurable care
Dr Desmond Graham
Dr Desmond Graham explores how early, structured care can help preserve function, maintain independence, and support healthy ageing.
Episode 4: The importance of early detection and diagnosis of MCI- Panel Discussion
(A/Prof Michael Woodward, A/Prof Mark Yates, Dr Marita Long)
Our experts discuss the signs of MCI, the role of GPs in recognising cognitive change, and why early detection supports timely assessment, referral, and patient care
Episode 5: Managing MCI in clinical practice- Panel Discussion
(A/Prof Michael Woodward, A/Prof Mark Yates, Dr Marita Long)
Our experts discuss the role of GPs in managing MCI, including early intervention, lifestyle modification, and coordinated care.
Episode 6: Follow-up After Diagnosis - Panel Discussion
(A/Prof Michael Woodward, A/Prof Mark Yates, Dr Marita Long)
Our experts discuss the importance of follow-up after diagnosis and how GPs and specialists can work together to deliver coordinated care.
Episode 7: Best Practice Multidisciplinary Management of MCI - Panel Discussion
(Dr Desmond Grahram and Dr Mark Hohenberg)
Our experts discuss the role of multidisciplinary care in MCI and how GPs can coordinate support across the patient journey.
Episode 8: Souvenaid Evidence - Frequently Asked Questions
A/Prof Michael Woodward
A/Prof Michael Woodward discusses the evidence for Souvenaid in early Alzheimer's disease, including its rationale, clinical data, and practical considerations for use, including the most frequently asked questions about the evidence.
Episode 9: Integrating Souvenaid into patient care
A/Prof Mark Yates
Professor Mark Yates discusses the practical integration of Souvenaid into the management of early Alzheimer's disease.
Episode 10: Practical conversations about Souvenaid
Dr Mark Hohenberg
Dr Mark Hohenberg discusses how to incorporate Souvenaid into conversations about managing MCI due to Alzheimer's disease, alongside lifestyle interventions and patient education.
Episode 11: Souvenaid case study
Dr Desmond Graham
Episode 12: Souvenaid case study
A/Prof Michael Woodward
Episode 13: Souvenaid case study
A/Prof Mark Yates
Nutricia products are intended for the nutritional management of diseases and related medical conditions and therefore should be used under medical supervision.
Please tell us who you are
?ts=1777457187445&&fmt=webp-alpha&dpr=off "Medical icon with stethoscope illustration"){kind=small}
Important notice and declaration
Breast milk is best for babies. Professional advice should be followed before using an infant formula. Introducing partial bottle feeding could negatively affect breast feeding. Good maternal nutrition is important for breast feeding and reversing a decision not to breast feed may be difficult. Infant formula should always be used as directed. Proper use of an infant formula is important to the health of the infant. Social and financial implications should be considered when selecting a method of feeding.
The information provided on this website is intended for use by healthcare professionals only. It is a condition of use of this site that you are a healthcare professional within the meaning of the Marketing in Australia of Infant Formulas (MAIF) Agreement or health practitioner within the meaning of the Therapeutic Goods Act 1989 (Cth). By accessing and using this website you acknowledge and declare that you are a registered healthcare professional. The content on this site is intended for general information and educational purposes only.